Day: February 9, 2022

The UK’s largest commercial source of news media audience will use Outbrain’s Smartfeed technology to grow revenue and drive engagement

LONDON, Feb. 09, 2022 (GLOBE NEWSWIRE) — Outbrain, a leading recommendation platform for the open web, today announced a new, multi-year deal with 1XL, the UK’s largest source of premium digital news media audiences as well as display inventory.

1XL, a division of Media Concierge and part of the Mediaforce Group, which owns the largest independent sales house in the UK, will adopt Outbrain as its exclusive recommendation provider. The strategic partnership will focus on growing revenue, supporting re-circulation and driving engagement including subscriptions across 1XL’s range of 43 established and trusted local news media publishers, including Newsquest, Johnston Press, Archant, Iliffe Media, and Tindle.

The deal will see 1XL rolling out Outbrain’s Smartfeed technology to diversify its revenue streams. Smartfeed provides customizable, dynamic, and tailored recommendations, which allows media owners to optimize the user experience, improve engagement, and revenue. It acts as a blank canvas on which a suite of unique cards can be used to deliver editorial, monetization, and specific revenue goals, generating a 20% RPM uplift, when compared to Outbrain’s standard widgets.

Outbrain’s Smartfeed will create prominent brand-safe spaces for advertisers to reach relevant consumers from 1XL’s 26.4 million user-base. Additionally, the deal will support highly targeted and personalized advertising campaigns, as well as feature prominent in-article placements, delivering a premium ad experience for top brands.

“Outbrain’s commitment to championing the open web and journalistic independence aligns with our mission to nurture a healthy presence of local publishers throughout the country,” said Scott Gill, Managing Director at 1XL. “Regional news outlets are essential to the UK’s democratic society and are an essential hub for local communities. Outbrain is a trusted and established partner whose best-in-class recommendation solution will support a range of growth objectives and, we feel, act in the interests of our publishers and their readers.”

“We consider the 1XL co-operative and its constituent publishers and sites valued partners that share our passion for providing unique, relevant, and engaging content,” said James Milne, Managing Director Northern Europe at Outbrain. “Overall, our placements, including our rich and highly viewable native in-article formats, will enhance the reader experience, diversify 1XL’s monetization strategies and bolster engagement. As a trusted partner, we are excited about the value our Smartfeed technology can offer across some of the UK’s oldest and most respected local news titles.”

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the federal securities laws, which statements involve substantial risks and uncertainties. Forward-looking statements generally relate to possible or assumed future results of our business, financial condition, results of operations, liquidity, plans and objectives. You can generally identify forward-looking statements because they contain words such as “may,” “will,” “should,” “expects,” “plans,” “anticipates,” “could,” “intends,” “target,” “projects,” “contemplates,” “believes,” “estimates,” “predicts,” “potential” or “continue” or the negative of these terms or other similar expressions that concern our expectations, strategy, plans or intentions. We have based these forward-looking statements largely on our current expectations and projections regarding future events and trends that we believe may affect our business, financial condition and results of operations. The outcome of the events described in these forward-looking statements is subject to risks, uncertainties and the risks described in the section entitled “Risk Factors” and elsewhere in the Quarterly Report on Form 10-Q filed for the quarter ended September 30, 2021 and in subsequent reports filed with the Securities and Exchange Commission. Accordingly, you should not rely upon forward-looking statements as predictions of future events. We cannot assure you that the results, events and circumstances reflected in the forward-looking statements will be achieved or occur, and actual results, events or circumstances could differ materially from those projected in the forward-looking statements. We undertake no obligation to update any forward-looking statement to reflect events or circumstances after the date on which the statement is made or to reflect the occurrence of unanticipated events. We do not assume any obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

About Outbrain

Outbrain (Nasdaq: OB) is a leading recommendation platform for the open web. Our technology enables 10 billion daily recommendations to consumers across more than 7,000 online properties and connects advertisers to these audiences to grow their business. Founded in 2006, Outbrain is headquartered in New York with offices in 18 cities worldwide.

About 1XL
1XL is a digital media display proposition comprised of 43 local and regional news publishers. With over 700 sites throughout the UK and Ireland, and a de-duplicated unique user reach of 30.9 million monthly (67% UK active user reach – comScore) our offering provides at-scale access to over half of the UK digital population across highly trusted established news titles. In an era of constantly changing news habits and business models, our news brands remain a consistent part of our readers’ lives. With our established news sites and accompanying social media channels, specialist titles, and content micro-hubs, the 1XL portfolio offers the scale exceeding that of a national Newsbrand with the ability to reach users against almost every geographically and contextually relevant environment. 1XL is a division of Media Concierge which is part of the Mediaforce Group.

Media Contact 
press@outbrain.com

Investor Relations Contact 
IR@outbrain.com
(332) 205-8999

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/82579585-f906-4b42-96de-4d7d6cf083b4

Global CDMO’s Heidelberg Facility Supplies more pDNA material to help address growing needs

Heidelberg, Germany, Feb. 08, 2022 (GLOBE NEWSWIRE) — AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced an expanded partnership to supply more plasmid DNA (pDNA) starting material for the Pfizer-BioNTech COVID-19 vaccine at the company’s Heidelberg facility.

According to a recent news release from Pfizer and BioNTech, the companies have started to develop an Omicron-based COVID-19 vaccine with first batches expected to be ready for delivery by end of March 2022.

“We are proud to continue to support BioNTech and supply them with pDNA materials for their vaccine production, as a part of the fight against new pandemic variants,” said AGC Biologics Chief Executive Officer, Patricio Massera. “Our pDNA services are a part of our growing global Cell and Gene Therapy offering that includes the development and manufacturing of cell therapies, viral vectors, and messenger RNA.”

“This type of work is what drives us every day,” says AGC Biologics General Manager, Heidelberg, Dieter Kramer. “We appreciate this opportunity to help make a difference in the lives of people around the world and produce life-saving treatments.”

The AGC Biologics Heidelberg facility has more than 20 years of experience delivering a wide range of programs for customers. The site is the company’s Center of Excellence for pDNA production, and a central part of the AGC Biologics global network of cell and gene therapy-focused facilities, with additional locations in Milan, Italy and Longmont, Colorado, USA.

For more information on AGC Biologics’ Plasmid DNA offering visit www.agcbio.com/plasmid-dna. To learn more about the company’s broader cell and gene therapy services visit www.agcbio.com/cell-therapy.

About AGC Biologics
AGC Biologics is a leading global biopharmaceutical Contract Development and Manufacturing Organization (CDMO) with a strong commitment to delivering the highest standard of service as we work side-by-side with our clients and partners, every step of the way. We provide world-class development and manufacture of mammalian and microbial-based therapeutic proteins, plasmid DNA (pDNA), messenger RNA (mRNA), viral vectors, and genetically engineered cells. Our global network spans the U.S., Europe, and Asia, with cGMP-compliant facilities in Seattle, Washington; Boulder and Longmont, Colorado; Copenhagen, Denmark; Heidelberg, Germany; Milan, Italy; and Chiba, Japan and we currently employ more than 2,000 employees worldwide. Our commitment to continuous innovation fosters the technical creativity to solve our clients’ most complex challenges, including specialization in fast-track projects and rare diseases. AGC Biologics is the partner of choice. To learn more, visit www.agcbio.com.

Nick McDonald
AGC Biologics
(425) 419-3555
nmcdonald@agc.com

SOUTHBOROUGH, Mass., Feb. 08, 2022 (GLOBE NEWSWIRE) — Virtusa Corporation (“Virtusa”), a leading IT services provider that enables the digital transformation of Global 2000 enterprises by designing, building, and implementing the end-to-end technology solutions that are essential to compete in a digital-first world, today announced the expiration of its previously announced solicitation of consents (the “Consent Solicitation”) and the receipt of the Requisite Consents (as defined below) from the holders (the “Holders”) of the 7.125% Senior Notes due 2028 (the “Notes”) issued by Virtusa and Austin HoldCo Inc., a Delaware corporation (together with Virtusa, the “Issuers”) necessary to effect the amendment (the “Amendment”) to the indenture governing the Notes (as supplemented, the “Indenture”), as described in the Issuers’ Consent Solicitation Statement dated January 31, 2022 (the “Statement”).

The Consent Solicitation expired at 5:00 PM, New York City Time, on February 8, 2022 (the “Expiration Date”). The Holders of a majority in aggregate principal amount of the outstanding Notes have validly delivered and did not revoke consents to the Proposed Amendment (the “Requisite Consents”). Accordingly, the Issuers, the guarantors party to the Indenture and the Indenture trustee will execute a supplemental indenture to the Indenture (the “Supplemental Indenture”) to effect the Amendment. The time and date on which the Supplemental Indenture is executed is hereinafter referred to as the Consent Time.

The Issuers will pay to the Holders who delivered valid and unrevoked consents to the Amendment on or prior to the Expiration Date (the “Consenting Holders”) an amount equal to $10 per $1,000 in principal amount of Notes (the “Consent Payment”) held by the Consenting Holders to the Depository Trust Company (“DTC”) for the benefit of the Consenting Holders, subject to the terms and conditions set forth in the Statement. The Issuers expect to pay, or cause to be paid, the Consent Payment on February 15, 2022 (the “Settlement Date”). No accrued interest will be paid in respect of the Consent Payment.

Although the Supplemental Indenture and the related Amendment will become effective immediately upon execution at the Consent Time, the Amendment will not be operative until the Consent Payment is paid to DTC for the benefit of the Consenting Holders on the Settlement Date.

BofA Securities is the solicitation agent in the Consent Solicitation and D.F. King & Co, Inc. has been retained to serve as the information and tabulation agent. Persons with questions regarding the Consent Solicitation should contact BofA Securities at 980-388-3646 or debt_advisory@bofa.com. Requests for the Statement should be directed to D.F. King & Co, Inc. at 212-269-5550 (Banks and Brokers), 800-431-9646 (All Others Toll Free) or by email at virtusa@dfking.com

None of the Issuers, the solicitation agent, the information and tabulation agent or the indenture trustee makes any recommendation as to whether Holders of the Notes should deliver any consents. Each Holder must make its own decision as to whether or not to deliver consents.

This press release is for informational purposes only and is neither an offer to sell nor a solicitation of an offer to buy any security. This announcement is also not a solicitation of consents with respect to the Proposed Amendments or otherwise. The Consent Solicitation is being made solely through the Statement referred to above and related materials. The Consent Solicitation is not being made to Holders of Notes in any jurisdiction in which the Issuers are aware that the making of the Consent Solicitation would not be in compliance with the
laws of such jurisdiction. In any jurisdiction in which the securities laws or blue sky laws require the Consent Solicitation to be made by a licensed broker or dealer, the Consent Solicitation will be deemed to be made on the Issuers’ behalf by the solicitation agent or one or more registered brokers or dealers that are licensed under the laws of such jurisdiction. Neither the Statement nor any documents related to the Consent Solicitation have been filed with, and have not been approved or reviewed by, any federal or state securities commission or regulatory authority of any country. No authority has passed upon the accuracy or adequacy of the Statement or any documents related to the Consent Solicitation, and it is unlawful and may be a criminal offense to make any representation to the contrary.

Forward-Looking Statements

This communication contains forward-looking statements. The Company generally identifies forward-looking statements by terminology such as “may,” “will,” “should,” “expects,” “plans,” “anticipates,” “could,” “intends,” “target,” “projects,” “contemplates,” “believes,” “estimates,” “predicts,” “potential” or “continue” or the negative of these terms or other similar words. These statements are only predictions. The Company has based these forward-looking statements largely on its then-current expectations and projections about future events and financial trends as well as the beliefs and assumptions of management. Forward-looking statements are subject to a number of risks and uncertainties, many of which involve factors or circumstances that are beyond the Company’s control. The Company’s actual results could differ materially from those stated or implied in forward-looking statements due to a number of factors, including but not limited to, those risks detailed in the Company’s most recent Annual Report. Accordingly, you should not rely upon forward-looking statements as predictions of future events. The Company cannot assure you that the events and circumstances reflected in the forward-looking statements will be achieved or occur, and actual results could differ materially from those projected in the forward-looking statements. The forward-looking statements made in this communication relate only to events as of the date on which the statements are made. Except as required by applicable law or regulation, the Company undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date on which the statement is made or to reflect the occurrence of unanticipated events.

About Virtusa

Virtusa Corporation is a global provider of digital engineering and information technology (IT) outsourcing services that accelerate business outcomes for its clients. Virtusa supports Global 2000 clients across key industries including banking, financial services, insurance, healthcare, communications, technology, and media and entertainment.

Virtusa helps improve business performance through accelerating revenue growth, delivering compelling consumer experiences, improving operational efficiencies, and lowering overall IT costs. Virtusa provides services across the entire spectrum of the IT services lifecycle, from consulting, to technology and user experience design, development of IT applications, systems integration, digital engineering, testing and business assurance, and maintenance and support services, including cloud, infrastructure and managed services. Virtusa helps its clients solve critical business problems by leveraging a combination of its distinctive consulting approach, end-to-end digital engineering capabilities, unique platforming methodology, and deep domain and technology expertise.

About BPEA

Baring Private Equity Asia (BPEA) is one of Asia’s largest private alternative investment firms, with assets under management of over $37 billion. BPEA manages a private equity investment program, sponsoring buyouts and providing growth capital to companies for expansion or acquisitions with a particular focus on the Asia Pacific region, as well as dedicated funds focused on private real estate and private credit. The firm has a 25-year history and over 210 employees located across 10 offices in Beijing, Delhi, Hong Kong, London, Los Angeles, Mumbai, Singapore, Shanghai, Sydney, and Tokyo.

Media Contact:

Matt Berry
Conversion Marketing
matt@conversionam.com

เตเมคูลา แคลิฟอร์เนีย, Feb. 09, 2022 (GLOBE NEWSWIRE) — กลุ่มพลังงานสะอาดและก๊าซอุตสาหกรรมของ Nikkiso Cryogenic Industries (กลุ่ม) ซึ่งเป็นบริษัทในเครือของ Nikkiso Co., Ltd (ประเทศญี่ปุ่น) มีความยินดีที่จะประกาศว่า Marsel Khaliullin ได้รับการเสนอชื่อให้เป็นผู้จัดการสายงานธุรกิจของ Aftermarket Services Russia และ Cryogenic Industries Service สำหรับ Nikkiso Industrial Russia (NIR)

เขาจะจัดการและสนับสนุน Aftermarket Services ซึ่งอยู่ในรัสเซีย โดยรายงานต่อ Ayman Zeitoun สำหรับ NIR และ Jim Estes สำหรับ CIS

Marsel มีประสบการณ์มากกว่า 20 ปีในการทำงานในตำแหน่งต่าง ๆ ในธุรกิจการซ่อมบำรุงและวิศวกรรมที่เกี่ยวข้องกับอุปกรณ์หมุน รวมถึงประสบการณ์ 6 ปีที่ผ่านมาในด้านอุตสาหกรรมน้ำมันและก๊าซในอิรัก อีกทั้งยังมีประสบการณ์การทำงานร่วมกับบริษัทต่างประเทศอีก 10 ปีอีกด้วย ในช่วงสองปีที่ผ่านมา Marsel ได้จัดการเวิร์กช็อปอุปกรณ์หมุนให้แก่ SPM Oil & Gas ซึ่งเป็นบริษัทของ Caterpillar

Ayman Zeitoun รองประธานและกรรมการผู้จัดการ – ประเทศรัสเซีย – ฝ่ายปฏิบัติการกล่าวว่า “ประสบการณ์และความรู้ในอุตสาหกรรมของคุณ Marsel จะเป็นประโยชน์อย่างยิ่งต่อ NIR และเราหวังว่าเขาจะให้ความช่วยเหลือเราได้เป็นอย่างดี”

นอกจากนี้ Nikkiso ยังคงมุ่งมั่นที่จะแสดงตัวตนให้เป็นที่ประจักษ์แก่ลูกค้า ทั้งในระดับสากลและระดับท้องถิ่น

ข้อมูลเกี่ยวกับ CRYOGENIC INDUSTRIES
บริษัทสมาชิก Cryogenic Industries, Inc. (ปัจจุบันเป็นสมาชิกของ Nikkiso Co., Ltd.) ผลิตอุปกรณ์แปรรูปก๊าซไครโอเจนทางวิศวกรรมและโรงงานขนาดเล็กสำหรับแปรรูปก๊าซธรรมชาติเหลว (LNG) บริการจัดการหลุมปิโตรเลียมหลังการขุดเจาะ และอุตสาหกรรมก๊าซสำหรับอุตสาหกรรม Cryogenic Industries ก่อตั้งขึ้นเมื่อ 50 ปีที่แล้ว โดยเป็นบริษัทแม่ของ ACD, Cosmodyne และ Cryoquip และเป็นกลุ่มที่ควบคุมโดยทั่วไปซึ่งมีหน่วยงานปฏิบัติการประมาณ 20 แห่ง

สำหรับข้อมูลเพิ่มเติม โปรดไปที่ www.nikkisoCEIG.com และ www.nikkiso.com.

สำหรับการติดต่อด้านสื่อ:
Anna Quigley
+1.951.383.3314
aquigley@cryoind.com

Mender.io has released a new integration with Microsoft Azure IoT Hub for more secure and robust IoT device management at scale.

PALO ALTO, Calif., Feb. 08, 2022 (GLOBE NEWSWIRE) — Mender.io (a Northern.tech solution) has released a new integration with Microsoft Azure IoT Hub. Mender.io is the market-leading OTA software updates management solution for connected devices.

Intended for IoT product managers, software architects and embedded developers, this new Azure integration offers provisioning of devices in the Mender server by automatically connecting them to Azure IoT Hub. The key benefit is that users can provision and manage devices from one “device-centric” web UI, reduce user complexity and minimize device-side credentials that need to be protected resulting in stronger security.

Azure Device Twins is also nested in Mender.io so users can avoid making their own homegrown device portal for merging data. Instead, they can manage all of their device information through one simple Mender web interface, making it easier and more efficient. Users can also use Mender.io for Azure IoT Hub-generated information to define software deployments.

When Mender.io and Azure IoT Hub are combined, enterprise users get all the functionality needed to achieve secure device software lifecycle management through a single pane of glass. This includes the ability to update target devices in advanced ways including:

• Update rollback in the event of an update failure
• Phased rollout
• Synchronized updates
• Delta updates

Without the integration, a user would need to somehow find a way to transfer the credentials from the Azure backend to each and every device, making it a painful process, specifically when scaling up a device fleet.

Mender CTO Eystein Måløy Stenberg said of this integration: “It saves time and hassle by providing a single interface for device life cycle management and automatically provisioning devices to be ready to use, so you can focus on creating valuable services for your customers instead of building infrastructure.”

Read about the full Azure integration here

For media inquiries:

Contact: Farshad Tavakoli

Email: farshad.tavakoli@northern.tech

Related Images

Image 1: Mender.io

Logo of Mender.io OTA software updates management solution

This content was issued through the press release distribution service at Newswire.com.

Attachment

• Mender.io